QUESTCOR PHARMACEUTICALS INC 4
4 · QUESTCOR PHARMACEUTICALS INC · Filed Aug 18, 2014
Insider Transaction Report
Form 4
Whitcup Scott M
Director
Transactions
- Disposition to Issuer
Common Stock
2014-08-14−4,183→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2014-08-14−13,530→ 0 totalExercise: $35.78Exp: 2022-02-14→ Common Stock (13,530 underlying) - Disposition to Issuer
Stock Option (right to buy)
2014-08-14−3,803→ 0 totalExercise: $40.37Exp: 2022-05-09→ Common Stock (3,803 underlying) - Disposition to Issuer
Stock Option (right to buy)
2014-08-14−9,203→ 0 totalExercise: $34.86Exp: 2023-05-23→ Common Stock (9,203 underlying)
Footnotes (4)
- [F1]Pursuant to Agreement and Plan of Merger, dated April 5, 2014 (the "Merger Agreement"), by and among Mallinckrodt plc ("Mallinckrodt"), Quincy Merger Sub, Inc. and Questcor Pharmaceuticals, Inc. ("Questcor"), Mallinckrodt acquired Questcor in a merger transaction (the "Merger") which closed at 4:30 p.m. EST, on August 14, 2014 (the "Effective Time"). At the Effective Time, each share of Questcor common stock (except for certain shares defined in the Merger Agreement) converted into the right to receive, without interest, (a) $30.00 in cash and (b) 0.897 of an ordinary share of Mallinckrodt, in exchange for such share of Questcor common stock ("Merger Consideration").
- [F2]Pursuant to terms of the Merger, at the Effective Time, each Questcor stock option, whether vested or unvested, held by Questcor non-employee directors converted into the right to receive the Merger Consideration with respect to each share of Company common stock subject to such option immediately prior to the effective time of the Merger, net of the applicable exercise price.
- [F3]The stock option is exercisable and vests in equal monthly installments over 48 months from the grant date of February 15, 2012.
- [F4]Fully exercisable.